Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2018

Jun 4, 2018

30016_dirs_2018-06-04_6b1474d7-e906-4e94-89e0-963857297616.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2018-06-01

Reporting Person: Turner Kathy V (Corporate Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-06-01 Common Stock M 466 Acquired 3272 Direct
2018-06-01 Common Stock F 113 $215.36 Disposed 3159 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-06-01 Restricted Stock Unit $ M 466 Disposed Common Stock (466) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 100 Indirect

Footnotes

F1: Closing price of Issuer's common stock on the NASDAQ market on June 1, 2018.

F2: The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein.

F3: These restricted stock units are part of a grant made to the reporting person on June 1, 2014 that have vested. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary of the date of grant. The number of restricted stock units reported was adjusted to reflect a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015.

F4: Not applicable.